PPARG and type 2 diabetes mellitus: Chemically synthesized PPAR-γ agonists, such as thiazolidines, can selectively activate PPAR-γ to increase the peripheral sensitivity to insulin and reduce the blood glucose level and are commonly used to treat type 2 diabetes.